Most recently, it has been discovered that conolidine and the above mentioned derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in identical regions as classical opioid receptors, it binds to a wide array of endogenous opioids. Compared with most opioid receptors, this receptor acts being a scavenger https://johni614ktv4.creacionblog.com/profile